Quarterly Statement Of Cash Flows

BrightPath Biotherapeutics Co., Ltd. - Filing #7539631

Concept 2023-04-01 to
2023-09-30
As at
2023-09-30
As at
2023-03-31
2022-04-01 to
2022-09-30
As at
2022-09-30
As at
2022-03-31
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-552,972,000 JPY
-809,792,000 JPY
Depreciation
48,000 JPY
8,359,000 JPY
Impairment losses
1,406,000 JPY
JPY
Interest and dividend income
-6,000 JPY
-11,000 JPY
Decrease (increase) in trade receivables
24,000 JPY
16,506,000 JPY
Increase (decrease) in trade payables
-64,000 JPY
-63,000 JPY
Other, net
86,468,000 JPY
198,200,000 JPY
Subtotal
-464,436,000 JPY
-585,995,000 JPY
Interest and dividends received
9,000 JPY
13,000 JPY
Interest paid
JPY
-202,000 JPY
Income taxes paid
-1,900,000 JPY
-2,420,000 JPY
Net cash provided by (used in) operating activities
-466,327,000 JPY
-588,604,000 JPY
Cash flows from investing activities
Net cash provided by (used in) investing activities
-1,454,000 JPY
JPY
Cash flows from financing activities
Redemption of bonds
JPY
-87,500,000 JPY
Purchase of treasury shares
JPY
0 JPY
Net cash provided by (used in) financing activities
JPY
197,491,000 JPY
Net increase (decrease) in cash and cash equivalents
-467,781,000 JPY
-391,113,000 JPY
Cash and cash equivalents
1,063,188,000 JPY
1,530,969,000 JPY
1,913,913,000 JPY
2,305,026,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.